Dahm Christina C, Moore Kevin, Murphy Michael P
Medical Research Council Dunn Human Nutrition Unit, Wellcome Trust/Medical Research Council Building, Hills Road, Cambridge CB2 2XY, United Kingdom.
J Biol Chem. 2006 Apr 14;281(15):10056-65. doi: 10.1074/jbc.M512203200. Epub 2006 Feb 14.
S-nitrosation of mitochondrial proteins has been proposed to contribute to the pathophysiological interactions of nitric oxide (NO) and its derivatives with mitochondria but has not been shown directly. Furthermore, little is known about the mechanism of formation or the fate of these putative S-nitrosothiols. Here we have determined whether mitochondrial membrane protein thiols can be S-nitrosated on exposure to free NO from 3,3-bis(aminoethyl)-1-hydroxy-2-oxo-1-triazene (DETA-NONOate) by interaction with S-nitrosoglutathione or S-nitroso-N-acetylpenicillamine (SNAP) and by the NO derivative peroxynitrite. S-Nitrosation of protein thiols was measured directly by chemiluminescence detection. S-Nitrosoglutathione and S-nitroso-N-acetylpenicillamine led to extensive protein thiol oxidation, with about 30% of the modified protein thiols persistently S-nitrosated. In contrast, there was no protein thiol oxidation or S-nitrosation on exposure to 3,3-bis (aminoethyl)-1-hydroxy-2-oxo-1-triazene. Peroxynitrite extensively oxidized protein thiols but produced negligible amounts of S-nitrosothiols. Therefore, mitochondrial membrane protein thiols are S-nitrosated by preformed S-nitrosothiols but not by NO or by peroxynitrite. These S-nitrosated protein thiols were readily reduced by glutathione, so S-nitrosation will only persist when the mitochondrial glutathione pool is oxidized. Respiratory chain complex I was S-nitrosated by S-nitrosothiols, consistent with it being an important target for S-nitrosation during nitrosative stress. The S-nitrosation of complex I correlated with a significant loss of activity that was reversed by thiol reductants. S-Nitrosation was also associated with increased superoxide production from complex I. These findings point to a significant role for complex I S-nitrosation and consequent dysfunction during nitrosative stress in disorders such as Parkinson disease and sepsis.
线粒体蛋白的S-亚硝基化被认为有助于一氧化氮(NO)及其衍生物与线粒体之间的病理生理相互作用,但尚未得到直接证实。此外,对于这些假定的S-亚硝基硫醇的形成机制或命运知之甚少。在这里,我们通过与S-亚硝基谷胱甘肽或S-亚硝基-N-乙酰青霉胺(SNAP)相互作用以及通过NO衍生物过氧亚硝酸根,来确定线粒体膜蛋白硫醇在暴露于来自3,3-双(氨基乙基)-1-羟基-2-氧代-1-三氮烯(DETA-NO)的游离NO时是否会发生S-亚硝基化。通过化学发光检测直接测量蛋白硫醇的S-亚硝基化。S-亚硝基谷胱甘肽和S-亚硝基-N-乙酰青霉胺导致广泛的蛋白硫醇氧化,约30%的修饰蛋白硫醇持续发生S-亚硝基化。相比之下,暴露于3,3-双(氨基乙基)-1-羟基-2-氧代-1-三氮烯时没有蛋白硫醇氧化或S-亚硝基化。过氧亚硝酸根广泛氧化蛋白硫醇,但产生的S-亚硝基硫醇量可忽略不计。因此,线粒体膜蛋白硫醇是通过预先形成的S-亚硝基硫醇而非NO或过氧亚硝酸根发生S-亚硝基化。这些S-亚硝基化的蛋白硫醇很容易被谷胱甘肽还原,所以只有当线粒体谷胱甘肽池被氧化时S-亚硝基化才会持续。呼吸链复合体I被S-亚硝基硫醇S-亚硝基化,这与它在亚硝化应激期间作为S-亚硝基化的重要靶点一致。复合体I的S-亚硝基化与显著的活性丧失相关,而硫醇还原剂可逆转这种活性丧失。S-亚硝基化还与复合体I产生超氧化物增加有关。这些发现表明,在帕金森病和败血症等疾病的亚硝化应激过程中,复合体I的S-亚硝基化及其随后的功能障碍具有重要作用。